glp-1 medical weight loss clinic daytona Tirzepatide Mounjaro® - Beach, FL | Injections for Obesity treatment Find the Best Medical Weight

Tirzepatide is the first dual agonist which has been approved for chronic weight management, but numerous other dual and/or triple agonists (cagrisema, retatrutide, mazdutide and survodutide) are also in phase 3 trials as potential treatments for obesity and its metabolic complications

Are GLP-1 drugs first-line treatments for diabetes

10.1038/nrendo.2017.91 131 ShiraziR

Long-term safety is under study

For more information, you can visit the FDA's official announcement at the link provided: Love the announcement of a redacted list.

Patients should be advised to report any worsening of digestive symptoms promptly, and dose titration may need to be slower than standard protocols to optimise tolerance